GMAB:NASDAQ
Genmab A/S - ADR
$34.83
arrow_upward
+0.23%(+0.080) 1D
$34.83
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 24, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$34.69
High
$35.03
Low
$33.22
Mkt. cap
21.96B
Avg. vol.
2.45M
Volume
0.00
P/E ratio
27.44
52-wk high
$35.66
52-wk low
$23.62
EPS
$1.27
Beta
0.84
Shares outstanding
624.06M
No. of employees
3K
Open
$34.69
High
$35.03
Low
$33.22
Mkt. cap
21.96B
Avg. vol.
2.45M
Volume
0.00
P/E ratio
27.44
52-wk high
$35.66
52-wk low
$23.62
EPS
$1.27
Beta
0.84
Shares outstanding
624.06M
No. of employees
3K
News stories
From web sources and news partners
TipRanks
·
11 hours ago
Genmab Grants New Employee Restricted Stock Units and Warrants
Stock Titan
·
12 hours ago
Employees at Genmab (GMAB) receive free share awards and rights to buy shares at DKK 2,268.
GlobeNewswire
·
12 hours ago
Grant of Restricted Stock Units and Warrants to Employees in Genmab
AD HOC NEWS
·
1 day ago
Genmab stock heads into the open after a 0.84 percent gain
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com